ACL
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Australian Clinical Labs Limited is a provider of pathology diagnostic services in Australia. The company operates a national network of NATA-accredited laboratories and collection centres, delivering community and hospital pathology services to clinicians, patients, hospitals, and corporate clients. Its business includes general pathology, molecular testing, and specialised diagnostics such as oncological genomics, reproductive health testing, and skin cancer clinics. The company serves markets in Victoria, New South Wales, Western Australia, South Australia, Queensland, the Northern Territory, and the Australian Capital Territory. It is a primary pathology provider to major private hospital groups and offers services through brands including SunDoctors, SouthernSun Pathology, Specialised Trials, BeFunctional Labs, and Gribbles Veterinary Pathology. The company utilizes a single national Laboratory Information System to support operational efficiency and digital billing initiatives.

Summarised from the company's own disclosures, fiscal year ended Jun 2026

Industry Health Care Equipment & Services Homepage clinicallabs.com.au
Sector Healthcare IR page investors.clinicallabs.com.au
Tags
pathology, diagnostic services, molecular testing, genomics, skin cancer clinics, hospital pathology, community pathology, veterinary pathology, clinical trials, reproductive health, SunDoctors, SouthernSun Pathology, Specialised Trials, BeFunctional Labs, Gribbles Veterinary Pathology
Press page —

Metrics

Valuation  
Market cap A$ 604.322M
Market cap (USD) $ 410.089M
P/E 25.86
PEG —
P/BV 3.45
P/S 0.82
P/OCF 3.70
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 14.9%
ROI 11.3%
ROIC 11.3%
Profit margin 3.3%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -12.7%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 41.4%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 5.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 735.753M 741.269M 696.368M 697.072M 995.604M 646.702M 490.57M
Net profit 24.016M 32.82M 24.244M 36.042M 178.402M 60.389M 41.255M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Share price 2.24 2.78 2.51 3.44 4.59 — —
Price performance 12m -0.19 0.11 -0.27 -0.25 — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Australian Clinical Labs Limited (ticker ACL), listed in Australia.

ETFs Holding Australian Clinical Labs Limited

ETF Weight in ETF Shares Market value As of
AVDS 0.02% 32,827 $ 73.739K Nov 16, 2026
DFIS 0.01% 348,876 $ 791.156K Nov 12, 2026
DXIV 0.01% 10,669 $ 24.194K Nov 12, 2026
DFSI 0.01% 28,118 $ 63.764K Nov 12, 2026
DFIC 0.00% 235,205 $ 533.381K Nov 12, 2026
DFAX 0.00% 143,919 $ 326.369K Nov 12, 2026
DFAI 0.00% 175,542 $ 398.082K Nov 12, 2026
AVDE 0.00% 331,599 $ 744.871K Nov 16, 2026
AVSD 0.00% 4,498 $ 10.104K Nov 16, 2026